Biban Forum 2025: Entrepreneurship World Cup Brings World’s Top Startups to Riyadh
RIYADH, Saudi Arabia, Oct. 27, 2025 /PRNewswire/ -- Riyadh is gearing up…
CompoSecure Schedules Third Quarter 2025 Conference Call for November 10th at 5:00 p.m. ET
October 27, 2025 16:05 ET | Source: CompoSecure, Inc. SOMERSET, N.J., Oct.…
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
October 27, 2025 16:05 ET | Source: Pulmonx Corporation Glen French, member…
CreatorWeek 2025 Launches in Macao, Offering a Unique, Vibrant Platform for Global Content Creators to Connect, Collaborate, and Innovate
MACAO, Oct. 27, 2025 /PRNewswire/ -- CreatorWeek Macao 2025, co-organized by Macao…
2025 Yangtze River Cultural Festival Opens in Zhangjiagang, Jiangsu
ZHANGJIAGANG, China, Oct. 27, 2025 /PRNewswire/ -- On October 24, the 2025 Yangtze…
Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular…
Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025
GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ -- India's 1st indigenously designed and…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
